4.44 pm | 12 Dec 2011 |  Source: CNBC-TV18

Dishman's Managing Director JR Vyas expects its key clients Abbott's contribution to grow by 50%. He further expects some more product orders coming i...

4.05 pm | 17 Nov 2011 |  Source: CNBC-TV18

Managing director of Dishman Pharmaceuticals, JR Vyas expects the topline growth to be 15% or even more going forward. He also added that the bottomli...

3.13 pm | 21 Sep 2011 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Dishman Pharma's chief financial officer VVS Murthy said that the change in rupee would not impact the company’s revenue...

3.55 pm | 21 Jul 2011 |  Source: CNBC-TV18

In an exclusive interview with CNBC-TV18, VVS Murthy, CFO of Dishman Pharma says that the company has announced a consolidated guidance of 21.5-22% EB...

3.30 pm | 13 Jun 2011 |  Source: CNBC-TV18

In an interview with CNBC-TV18, VVS Murthy, CFO, Dishman Pharma said the company is expecting 15% top-line and bottom-line growth in FY12....

5.09 pm | 22 Feb 2011 |  Source: CNBC-TV18

VVS Murthy, CFO of Dishman Pharma, in an interview with CNBC-TV18's Latha Venkatesh and Gautam Broker, spoke about the recent report by one of the bro...

6.59 pm | 14 Feb 2011 |  Source: CNBC-TV18

Dishman Pharma has reported a consolidated net profit of Rs 1.7 crore for the quarter ended December 2010 as against Rs 33 crore in same quarter, the ...